Latest Adverse event Stories
Enables healthcare organizations to harness the power of medical device data for clinical and operational improvements ANDOVER, Mass., Jan.
FDA’s new proposed rules will make drug manufacturers revamp the way they register data on ClinicalTrials.gov.
SANTA MONICA, Calif., Nov.
A recent regulatory filing exposes that adverse events occurred in 14% of patients taking Acthar in 2013.
A recent regulatory filing exposes that the number of adverse events in 2013 reported by patients taking Acthar was almost 14% of prescriptions.
Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, notes that Xarelto® is surpassing Pradaxa® in the number of reported adverse events, according to the Institute for Safe
GREENSBORO, N.C., July 3, 2014 /PRNewswire/ -- ConvaTec has announced that the U.S.
FDA Removes Clinical Hold on Phase 2 Trial (Study 202) SAN DIEGO, June 4, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
Important webinar to examine the first regulatory year of EU regulations regarding cosmetovigilance.
Live webinar will focus on the importance of consistent quality practices for management of veterinary pharmacovigilance, particularly, adverse event data.
- A political dynamiter.